Manufacturing and Production
Avillion appoints chief business officer
May 31, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Avillion
Pfizer, UCB sell plants to smaller drugmakers
May 30, 2013 Manufacturing and Production Pfizer, UCB
Bad pharma, good pharma: an insider’s view
May 30, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Bad pharma, Goldacre, NICE, transparancy
SCM Pharma appoints new director
May 30, 2013 Manufacturing and Production, Research and Development, Sales and Marketing SCM Pharma
FDA rejects Valeant’s efinaconazole on packaging grounds
May 29, 2013 Manufacturing and Production FDA, Valeant
Pharmaniaga joins push into MENA with Saudi JV
May 29, 2013 Manufacturing and Production MENA, Pharmaniaga, Saudi
Hurel appoints Schering-Plough executive to its Board
May 24, 2013 Manufacturing and Production, Research and Development, Sales and Marketing Hurel, Merck, Schering-Plough
Boehringer held up by FDA for production violations
May 24, 2013 Manufacturing and Production API, Boehringer, FDA
GSK to cull Australian tablet packaging plant
May 23, 2013 Manufacturing and Production Australia, GSK
Bayer hires chief information officer
May 23, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bayer, information
Board changes at Boehringer Ingelheim
May 22, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Boehringer, baiker
AndersonBrecon joins fast-growing contract packer PCI
May 21, 2013 Manufacturing and Production AndersonBrecon, PCI
Canada tightens GMP rules for active ingredients
May 21, 2013 Manufacturing and Production API, Canada, GMP
New general manager for Eisai in Mexico
May 21, 2013 Manufacturing and Production, Research and Development, Sales and Marketing
Working with the NHS in austerity
May 20, 2013 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, atkin, austerity, reforms, wellards
Latest content
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?
